Ryvu Therapeutics S.A. (RVU)
Market Closed
10 Aug, 14:50
WSE 
zł
15. 72
+0.14
+0.8986%
zł
1.21B Market Cap
- P/E Ratio
- Div Yield
21,454 Volume
0 Eps
zł 15.58
Previous Close Want to track RVU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ryvu Therapeutics S.A. (RVU) Statistics
Valuation metrics
Market Cap 1.21B
Enterprise value 388.21M
Trailing P/E (ttm) -3.98
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) 5.78
Price/Book (mrq) 8.72
Enterprise Value/Revenue 6.23
Enterprise Value/EBITDA -4.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 25.86K
Average volume (90 days) 42.75K
Price summary
52-Week low 13.64
52-Week high 31.9
Beta -
50-Day moving average 14.85
200-Day moving average 20.76
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.42%
Operating margin -1.51%
Operational effectiveness
Return on assets -0.44%
Return on equity -1.35%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.69
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.42
Total debt (mrq) -
Total Debt/Equity (mrq) 1.78
Current ratio (mrq) 2.26%
Book value per share (mrq) 1.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
